Form4insider filings, from the source

Insider holders · CIK 0001559356

Immune Therapeutics, Inc. · IMUN

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Richard Gostanianrelationship not stated12,949,02712,949,02725,898,054Apr 2, 2018 · 9:08 pm EDTForm 5
Robert Jackman Daileyrelationship not stated20,800,359—20,800,359Mar 30, 2018 · 5:03 pm EDTForm 5
Noreen GriffinCHIEF EXECUTIVE OFFICER7,317,7104,317,71011,635,420Jul 26, 2016 · 1:35 pm EDTForm 5
Paul AkinDirector5,090,742—5,090,742May 2, 2016 · 5:19 pm EDTForm 3
Christopher PearceCHIEF OPERATING OFFICER2,876,125—2,876,125Jul 22, 2016 · 5:48 pm EDTForm 4
Vincent ButtaDirector—1,250,0001,250,000Jan 15, 2015 · 11:08 am ESTForm 4
Seth ElliottPRESIDENT/ COO1,250,000—1,250,000Jan 15, 2015 · 10:55 am ESTForm 4
Eugene YoukilisPRESIDENT1,121,808—1,121,808Feb 12, 2015 · 5:21 pm ESTForm 5
Clifford SelskyDirector—250,000250,000Apr 13, 2016 · 3:35 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.